Investors evaluating the insurance sector often weigh growth potential against stability, and few pairings illustrate that trade-off as cleanly as AFL and UNM. Aflac Incorporated and Unum Group both operate in the protection and benefits space, yet their business models, geographic exposures, and risk profiles are distinct. This stock comparison is relevant for income-oriented investors, dividend seekers, and traders monitoring relative performance and market positioning across two established insurers. By examining recent market activity, underlying fundamentals, and momentum, readers can better understand how these two names compare in the current environment.
AFL, or Aflac Incorporated, is a Columbus, Georgia–based provider of supplemental health and life insurance, best known for its voluntary accident, cancer, and hospital indemnity products. The company operates across two major markets: the United States and Japan, the latter representing a substantial share of earnings. With a market capitalization of roughly $59 billion, Aflac is one of the largest supplemental insurers globally.
In recent market activity, Aflac's shares have advanced modestly, gaining in the mid-single digits year to date, but have underperformed the broader S&P 500 over the trailing year. The company's Japan segment has been a bright spot, with new annualized premium sales rising in the double digits on strong uptake of cancer and medical products such as Miraito and Anshin Palette. However, overall earned premiums in Japan have declined modestly in yen terms, reflecting higher lapses and reinsurance headwinds. In the U.S., group benefits and voluntary product sales have grown, though recent quarterly earnings per share (EPS) came in below consensus estimates. Aflac has maintained aggressive capital returns, repurchasing billions of dollars in stock and raising its quarterly dividend by roughly 5% in early 2026, while analysts largely rate the shares a "Hold" with a forward P/E above its historical median.
UNM, or Unum Group, is a provider of group and individual income-protection products, including group disability, life, accident, and voluntary benefits, with operations in the United States, the United Kingdom, and Poland. With a market capitalization near $13 billion, Unum is a leading U.S. disability insurer, deriving most of its premiums from employer-sponsored plans distributed through brokers.
Unum has reported steady top-line momentum, with core operations premium growth in the low-to-mid single digits and a core adjusted return on equity of approximately 20% for recent periods. Sales momentum at its Colonial Life segment and double-digit international premium growth have supported the franchise. At the same time, quarterly results have been pressured by elevated benefit ratios in group disability, driven by lower claim recoveries and reduced mortality within claimant blocks, which caused earnings to miss consensus estimates in recent quarters. Unum has also materially reduced its legacy long-term care (LTC) exposure through a reinsurance transaction with Fortitude Re, lowering reserve volatility and sharpening focus on its core employee-benefits business. Management has guided to premium growth of 4% to 7% and EPS growth of 8% to 12%, supported by continued buybacks and dividend increases.
For traders seeking a data-driven edge, Tickeron's Trending AI Robots page offers a curated view of AI-powered trading bots that navigate thousands of tickers across the market. Tickeron maintains hundreds of AI Trading Bots, each built around distinct trading styles, strategies, timeframes, performance statistics, and sets of securities. Only the bots best suited to current market conditions earn a place in this rotating, curated selection, helping users filter through the noise to identify tools with demonstrated momentum and consistency. Whether your focus is short-term swing trading or longer-horizon positioning, exploring the Trending AI Robots section can provide a practical starting point for incorporating algorithmic analysis into your own research on names such as AFL and UNM.
Although both companies are insurers, their exposures differ sharply. Aflac's model is weighted toward supplemental and voluntary products sold at the worksite and through Japan's distribution channels, giving it significant foreign-currency and interest-rate sensitivity tied to the yen. Unum, by contrast, is an employer-paid group benefits leader whose earnings hinge more directly on disability claim incidence and recovery trends in mature Western markets.
On growth, Unum currently projects faster premium and EPS expansion, reflecting an improving sales pipeline and reduced legacy LTC risk. Aflac's growth story is more mixed: robust new product sales in Japan have yet to translate into premium growth, while its U.S. group business scales gradually. On stability, Aflac benefits from exceptionally high persistency in Japan and a fortress-like balance sheet, whereas Unum carries a smaller capital base but has made meaningful progress de-risking its closed block.
From a momentum and sentiment standpoint, neither name has been a standout relative to the broader market, though Aflac has outpaced the U.S. insurance ETF benchmark over the past year. Risk factors also diverge: Aflac faces currency translation and Japan demographic headwinds, while Unum faces claim-cost volatility and international margin pressure. In valuation, Aflac trades at a premium to its own historical forward P/E, while Unum's headline P/E sits near its 10-year high, suggesting limited multiple-driven upside for both unless earnings growth reaccelerates.
Based on observable factors such as trend consistency, stability, catalysts, and relative positioning, Tickeron's AI would likely lean toward UNM in the current environment, though the margin is modest. Unum's clearer top-line growth trajectory, its materially reduced long-term care risk, and a stated path toward high-single to low-double-digit EPS growth present a more defined catalyst set than Aflac's, which remains partly constrained by Japan premium declines and currency sensitivity. At the same time, Aflac's superior persistency, larger capital base, and consistent capital returns give it a stability edge that favors longer-horizon positioning. The verdict is therefore probabilistic rather than definitive: Unum may be favored for momentum and growth catalysts, while Aflac retains appeal for stability and income, depending on how each name's trend and volatility signals evolve in the weeks ahead.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for AFL turned positive on October 07, 2026. Looking at past instances where AFL's MACD turned positive, the stock continued to rise in 30 of 47 cases over the following month. The odds of a continued upward trend are 64%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on AFL as a result. In 47 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.
AFL moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AFL crossed bullishly above the 50-day moving average on October 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.
Following a +2.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where AFL advanced for three days, in 199 of 368 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
The 10-day RSI Indicator for AFL moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 18 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 45%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AFL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 38%.
AFL broke above its upper Bollinger Band on October 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AFL entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. AFL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.993) is normal, around the industry mean (1.310). P/E Ratio (12.944) is within average values for comparable stocks, (19.517). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (0.463). Dividend Yield (0.020) settles around the average of (0.047) among similar stocks. AFL's P/S Ratio (3.313) is slightly higher than the industry average of (1.303).
The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Aroon Indicator for UNM entered a downward trend on October 12, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 64 similar instances where the Aroon Indicator formed such a pattern. In 35 of the 64 cases the stock moved lower. This puts the odds of a downward move at 55%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 74 cases where UNM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 50%.
The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UNM as a result. In 40 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 47%.
UNM moved below its 50-day moving average on October 23, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 41%.
The Moving Average Convergence Divergence (MACD) for UNM just turned positive on October 08, 2026. Looking at past instances where UNM's MACD turned positive, the stock continued to rise in 38 of 52 cases over the following month. The odds of a continued upward trend are 73%.
The 10-day moving average for UNM crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +0.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where UNM advanced for three days, in 255 of 360 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
UNM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Profit vs. Risk Rating rating for this company is 2 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. UNM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.322) is normal, around the industry mean (1.310). P/E Ratio (20.898) is within average values for comparable stocks, (19.517). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (0.463). Dividend Yield (0.022) settles around the average of (0.047) among similar stocks. P/S Ratio (1.187) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
AFL | UNM | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 22 | 90 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 77 Overvalued | 60 Fair valued | |
PROFIT vs RISK RATING 1..100 | 3 | 2 | |
SMR RATING 1..100 | 94 | 95 | |
PRICE GROWTH RATING 1..100 | 47 | 47 | |
P/E GROWTH RATING 1..100 | 87 | 4 | |
SEASONALITY SCORE 1..100 | 75 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
UNM's Valuation (60) in the Life Or Health Insurance industry is in the same range as AFL (77). This means that UNM’s stock grew similarly to AFL’s over the last 12 months.
UNM's Profit vs Risk Rating (2) in the Life Or Health Insurance industry is in the same range as AFL (3). This means that UNM’s stock grew similarly to AFL’s over the last 12 months.
AFL's SMR Rating (94) in the Life Or Health Insurance industry is in the same range as UNM (95). This means that AFL’s stock grew similarly to UNM’s over the last 12 months.
AFL's Price Growth Rating (47) in the Life Or Health Insurance industry is in the same range as UNM (47). This means that AFL’s stock grew similarly to UNM’s over the last 12 months.
UNM's P/E Growth Rating (4) in the Life Or Health Insurance industry is significantly better than the same rating for AFL (87). This means that UNM’s stock grew significantly faster than AFL’s over the last 12 months.
| AFL | UNM | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 45% | N/A |
| Stochastic ODDS (%) | 3 days ago 45% | 3 days ago 50% |
| Momentum ODDS (%) | 3 days ago 60% | 3 days ago 47% |
| MACD ODDS (%) | 3 days ago 64% | 3 days ago 73% |
| TrendWeek ODDS (%) | 3 days ago 56% | 3 days ago 41% |
| TrendMonth ODDS (%) | 3 days ago 54% | 3 days ago 37% |
| Advances ODDS (%) | 12 days ago 54% | 4 days ago 71% |
| Declines ODDS (%) | 25 days ago 38% | 7 days ago 41% |
| BollingerBands ODDS (%) | 3 days ago 43% | 3 days ago 70% |
| Aroon ODDS (%) | 3 days ago 44% | 3 days ago 55% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AFL’s FA Score shows that 1 FA rating(s) are green while UNM’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AFL’s TA Score shows that 5 TA indicator(s) are bullish while UNM’s TA Score has 4 bullish TA indicator(s).
AFL (@Life/Health Insurance) experienced а +0.45% price change this week, while UNM (@Life/Health Insurance) price change was -2.11% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.70%. For the same industry, the average monthly price growth was -3.55%, and the average quarterly price growth was -4.55%.
AFL is expected to report earnings on Nov 04, 2026.
UNM is expected to report earnings on Nov 03, 2026.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
A.I.dvisor indicates that over the last year, AFL has been loosely correlated with CNO. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if AFL jumps, then CNO could also see price increases.
A.I.dvisor indicates that over the last year, UNM has been loosely correlated with CNO. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if UNM jumps, then CNO could also see price increases.